[PDF][PDF] Bacterial immunostimulants-mechanism of action and clinical application in respiratory diseases
A Roży… - Advances in Respiratory …, 2008 - journals.viamedica.pl
… Address for correspondence: Address for correspondence: Adriana Roży, Laboratory of
Molecular Diagnostics, National Institute of Tuberculosis and Lung Diseases, 26 Płocka Str …
Molecular Diagnostics, National Institute of Tuberculosis and Lung Diseases, 26 Płocka Str …
[HTML][HTML] Plasma markers of COVID-19 severity: a pilot study
…, S Janciauskiene, S Wrenger, S Volland, A Rozy… - Respiratory …, 2022 - Springer
Background SARS-CoV-2 infected patients show heterogeneous clinical presentations
ranging from mild symptoms to severe respiratory failure and death. Consequently, various …
ranging from mild symptoms to severe respiratory failure and death. Consequently, various …
[HTML][HTML] Acute phase proteins as early predictors for immunotherapy response in advanced NSCLC: an explorative study
MA Schneider, A Rozy, S Wrenger… - Frontiers in …, 2022 - frontiersin.org
In the last decade, targeting the immune system became a promising therapy in advanced
lung cancer stages. However, in a clinical follow-up, patient responses to immune checkpoint …
lung cancer stages. However, in a clinical follow-up, patient responses to immune checkpoint …
[HTML][HTML] The presence of T Allele (rs35705950) of the MUC5B gene predicts lower baseline forced vital capacity and its subsequent decline in patients with …
KB Lewandowska, M Szturmowicz… - International Journal of …, 2023 - mdpi.com
Hypersensitivity pneumonitis (HP) is an exposure-related interstitial lung disease with two
phenotypes—fibrotic and non-fibrotic. Genetic predisposition is an important factor in the …
phenotypes—fibrotic and non-fibrotic. Genetic predisposition is an important factor in the …
[HTML][HTML] Case report: Rare among ultrarare—Clinical odyssey of a new patient with Ogden syndrome
…, K Loranc, A Kruk, U Lechowicz, A Rozy… - Frontiers in …, 2022 - frontiersin.org
Introduction: The definition of ultra-rare disease in terms of its prevalence varies between the
sources, usually amounting to ca. 1 in 1.000.000 births. Nonetheless, there are even less …
sources, usually amounting to ca. 1 in 1.000.000 births. Nonetheless, there are even less …
[HTML][HTML] Factors Predictive for Immunomodulatory Therapy Response and Survival in Patients with Hypersensitivity Pneumonitis—Retrospective Cohort Analysis
KB Lewandowska, I Barańska, M Sobiecka… - Diagnostics, 2022 - mdpi.com
Hypersensitivity pneumonitis (HP) is one of the interstitial lung diseases with clearly established
diagnostic criteria. Nevertheless, pharmacologic treatment recommendations are still …
diagnostic criteria. Nevertheless, pharmacologic treatment recommendations are still …
[HTML][HTML] Clarithromycin decreases IL-6 concentration in serum and BAL fluid in patients with cryptogenic organizing pneumonia
E Radzikowska, A Roży, P Jagus… - … in Clinical and …, 2016 - advances.umw.edu.pl
Background. Inflammatory cytokines are involved in the development of cryptogenic organizing
pneumonia (COP). It has been shown that macrolides inhibit cytokine production in the …
pneumonia (COP). It has been shown that macrolides inhibit cytokine production in the …
Hypersensitivity pneumonitis recognised in a single pulmonary unit, between 2005 and 2015: comparison with recently proposed diagnostic criteria
M Szturmowicz, I Barańska, ME Jędrych… - … in Respiratory Medicine, 2019 - mdpi.com
Introduction: Hypersensitivity pneumonitis (HP) is the third most common interstitial lung
disease after idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Pathogenesis …
disease after idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Pathogenesis …
[HTML][HTML] Bronchoalveolar lavage cell count and lymphocytosis are the important discriminators between fibrotic hypersensitivity pneumonitis and idiopathic pulmonary …
M Sobiecka, M Szturmowicz, KB Lewandowska… - Diagnostics, 2023 - mdpi.com
Background: Fibrotic hypersensitivity pneumonitis (fHP) shares many features with other
fibrotic interstitial lung diseases (ILD), and as a result it can be misdiagnosed as idiopathic …
fibrotic interstitial lung diseases (ILD), and as a result it can be misdiagnosed as idiopathic …
[PDF][PDF] Increased levels of interleukin 27 in patients with early clinical stages of non-small cell lung cancer
P Kopiński, T Wandtke, A Dyczek… - Pol Arch Intern …, 2018 - scholar.archive.org
AbsTRACT INTROduCTION Interleukin 27 (IL-27) is a cytokine secreted mostly by antigen-
presenting cells. It is important for the immune polarization of T helper-1 (Th1) cells, and its …
presenting cells. It is important for the immune polarization of T helper-1 (Th1) cells, and its …